Report for: Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]

Title	Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
Published in	Trials, June 2022
DOI	10.1186/s13063-022-06345-2
Pubmed ID	35710572
Authors	Xuan Ying Poh, I. Russel Lee, Clarissa Lim, Jefanie Teo, Suma Rao, Po Ying Chia, Sean W. X. Ong, Tau Hong Lee, Ray J. H. Lin, Lisa F. P. Ng, Ee Chee Ren, Raymond T. P. Lin, Lin-Fa Wang, Laurent Renia, David Chien Lye, Barnaby E. Young

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Unknown	2	100%

Type	Count	As %
Members of the public	2	100%

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	47	100%

Readers by professional status	Count	As %
Student > Bachelor	5	11%
Student > Ph. D. Student	3	6%
Lecturer	3	6%
Researcher	3	6%
Student > Master	3	6%
Other	7	15%
Unknown	23	49%

Readers by discipline	Count	As %
Medicine and Dentistry	9	19%
Nursing and Health Professions	3	6%
Pharmacology, Toxicology and Pharmaceutical Science	3	6%
Business, Management and Accounting	2	4%
Social Sciences	2	4%
Other	3	6%
Unknown	25	53%

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]